Zelira Therapeutics Ltd (ZLD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2005 | 06-2004 | |
| Cash Flows From Operating Activities | ||
| Operating Cash Flow | $N/A | $N/A |
| Cash Flows From Investing Activities | ||
| PPE Investments | 14 | -45 |
| Purchase Sale Intangibles | -44 | -489 |
| Other Investing Activity | 0 | -1,161 |
| Investing Cash Flow | $-30 | $-1,695 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 2,051 | 6,061 |
| Common Stock Repurchased | -150 | -362 |
| Financing Cash Flow | $1,901 | $5,699 |
| Beginning Cash Position | 2,152 | 900 |
| End Cash Position | 1,460 | 2,152 |
| Net Cash Flow | $-692 | $1,252 |
| Free Cash Flow | ||
| Capital Expenditure | -75 | -1,056 |
| Free Cash Flow | -75 | -1,056 |